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Abstract 
Chlamydia are Gram-negative, obligate intracellular bacterial pathogens responsible for a broad spectrum of human 
and animal diseases. In humans, Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infec-
tion worldwide and is the causative agent of trachoma (infectious blindness) in disadvantaged populations. Over the 
course of its developmental cycle, Chlamydia extensively remodels its intracellular niche and parasitises the host cell 
for nutrients, with substantial resulting changes to the host cell transcriptome and proteome. However, little infor-
mation is available on the impact of chlamydial infection on the host cell epigenome and global gene regulation. 
Regions of open eukaryotic chromatin correspond to nucleosome-depleted regions, which in turn are associated 
with regulatory functions and transcription factor binding. We applied formaldehyde-assisted isolation of regulatory 
elements enrichment followed by sequencing (FAIRE-Seq) to generate temporal chromatin maps of C. trachomatis-
infected human epithelial cells in vitro over the chlamydial developmental cycle. We detected both conserved and 
distinct temporal changes to genome-wide chromatin accessibility associated with C. trachomatis infection. The 
observed differentially accessible chromatin regions include temporally-enriched sets of transcription factors, which 
may help shape the host cell response to infection. These regions and motifs were linked to genomic features and 
genes associated with immune responses, re-direction of host cell nutrients, intracellular signalling, cell–cell adhesion, 
extracellular matrix, metabolism and apoptosis. This work provides another perspective to the complex response to 
chlamydial infection, and will inform further studies of transcriptional regulation and the epigenome in Chlamydia-
infected human cells and tissues.
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Introduction
Members of the genus Chlamydia are Gram-negative, 
obligate intracellular bacterial pathogens responsible for 
a broad spectrum of human and animal diseases [1]. In 
humans, Chlamydia trachomatis is the most prevalent 
bacterial sexually transmitted infection (STI) [2], caus-
ing substantial reproductive tract disease globally [3], 
and is the causative agent of trachoma (infectious blind-
ness) in disadvantaged populations [4]. All members of 
the genus exhibit a unique biphasic developmental cycle 
where the non-replicating infectious elementary bodies 
(EBs) invade host cells and differentiate into replicating 
reticulate bodies (RBs) within a membrane-bound vacu-
ole, escaping phagolysomal fusion [5]. All chlamydial 
species actively modulate host cell processes to estab-
lish this intracellular niche, using secreted effectors and 
other proteins to facilitate invasion, internalisation and 
replication, while countering host defence strategies [6, 
7]. At the end of the developmental cycle, RBs condense 
into EBs, which are released from the host cell by lysis or 
extrusion to initiate new infections [8].
Bacterial interactions with mammalian cells can induce 
dynamic transcriptional responses from the cell, either 
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from innate immune signalling cascades and other cel-
lular responses [9–11]. In addition, bacterial effector 
proteins specifically targeting the nucleus (nucleomodu-
lins) can influence cell physiology and directly interfere 
with transcriptional machinery including chromatin 
remodelling, DNA replication and repair [12]. Host cell 
epigenetic-mediated transcriptional regulatory changes, 
including histone modifications, DNA methylation, chro-
matin accessibility, RNA splicing, and non-coding RNA 
expression [13–15] may also be arbitrated by bacterial 
proteins and effectors. Consistent with host cell inter-
actions with other bacterial pathogens, C. trachomatis 
infection alters host cell transcription over the course of 
its developmental cycle [16] and may also modulate the 
host cell epigenome. For example, NUE (NUclear Effec-
tor), a C. trachomatis type III secreted effector with 
methyltransferase activity, enters the host nucleus and 
methylates eukaryotic histones H2B, H3 and H4 in vitro 
[17]. However, the ultimate gene targets of NUE activity 
or the affected host transcriptional networks are unchar-
acterised, as is the influence of chlamydial infection on 
the host cell epigenome in general.
Genetic information in eukaryotes is compactly organ-
ised within the nucleus of each cell in highly ordered 
structures composed of DNA and proteins, designated 
chromatin. Cellular processes occur when chromatin 
fibres become less condensed, providing areas of open 
chromatin which allow transcription to proceed. Areas of 
open chromatin are associated with active DNA regula-
tory elements, including promoters, enhancers, silencers, 
and insulators. Chromatin accessibility is also relevant to 
alternative splicing, alternative promoter usage and alter-
native polyadenylation, where different forms of RNA are 
generated from the same gene [18]. Thus, the underlying 
structures (introns, exons, TSS and TTS) can be differ-
entially used and thus differentially accessed. To examine 
the impact of chlamydial infection on host cell chromatin 
dynamics, we applied FAIRE-Seq (formaldehyde-assisted 
isolation of regulatory elements sequencing) [19] to C. 
trachomatis-infected HEp-2 epithelial cells and time-
matched mock-infected cells, spanning the chlamydial 
developmental cycle (1, 12, 24 and 48 h post-infection). 
FAIRE protocols rely on the variable crosslinking effi-
ciency of DNA to nucleosomes by formaldehyde, where 
nucleosome-bound DNA is more efficiently crosslinked. 
DNA fragments that are not crosslinked are subsequently 
enriched in the aqueous phase during phenol–chloro-
form extraction. These fragments represent regions of 
open chromatin, which in turn can be associated with 
regulatory factor binding sites. In FAIRE-Seq, librar-
ies are generated from these enriched fragments, fol-
lowed by sequencing and read mapping to a reference 
genome [19], allowing patterns of chromatin accessibility 
to be identified [20]. We identify infection-responsive 
changes in chromatin accessibility over the chlamydial 
developmental cycle, and identify several candidate host 
transcription factors that may be relevant to the cellu-
lar response to chlamydial infection. We note that the 
experimental design used here cannot distinguish Chla-
mydia-mediated effects from infection-specific or non-
specific host cell responses. Further experiments with 
inactivated Chlamydia or selected gene knock-outs or 
knock-downs will help to elucidate the extent of specific 
Chlamydia-mediated interference with the host cell epig-
enome. We also note that the use of in vitro immortalised 
HEp-2 epithelial cells means that, despite their utility and 
widespread use in chlamydial research, the full diversity 
of host cell responses that are likely to be found within 
in vivo infections will not be captured.
Methods
Cell culture, infection and experimental design
HEp-2 cells (American Type Culture Collection, ATCC 
No. CCL-23) were grown as monolayers in 6 × 100 mm 
TC dishes until 90% confluent. Monolayers were infected 
with C. trachomatis serovar E in sucrose–phosphate–
glutamate (SPG) buffer as previously described [21]. 
Additional monolayers were mock-infected with SPG 
only. The infection was allowed to proceed 48 h prior to 
EB harvest, as previously described [21]. C. trachomatis 
EBs and mock-infected cell lysates were subsequently 
used to infect fresh HEp-2 monolayers. Fresh monolay-
ers were infected with C. trachomatis serovar E in 3.5 mL 
SPG buffer for an MOI ~ 1 as previously described [21], 
which routinely observes 95% + infectivity; centrifuga-
tion was used to synchronise infections. Infections and 
subsequent culture were performed in the absence of 
cycloheximide or DEAE dextran. A matching number 
of HEp-2 monolayers were also mock-infected using 
uninfected cell lysates. Each treatment was incubated at 
25  °C for 2  h and subsequently washed twice with SPG 
to remove dead or non-viable EBs. 10 mL fresh medium 
(DMEM + 10% FBS, 25  μg/mL gentamycin, 1.25  μg/mL 
fungizone) was added and cell monolayers incubated at 
37 °C with 5%  CO2. Three biological replicates of infected 
and mock-infected dishes per time were harvested post-
infection by scraping and resuspending cells in 150 μL 
sterile PBS. Resuspended cells were stored at − 80 °C.
FAIRE enrichment and sequencing
Formaldehyde-crosslinking of cells, sonication, DNA 
extraction of FAIRE-enriched fractions and Illu-
mina library preparation was performed as previously 
described [19]. Libraries were prepared in triplicate from 
infected and mock-infected samples at 1, 12, 24 and 48 h, 
using the Illumina TruSeq Sample Prep kit, and were 
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sequenced on the Illumina 2500 platform (101 bp paired-
end read protocol) at the Genome Resource Centre, Insti-
tute for Genome Sciences, University of Maryland School 
of Medicine. Sequence data are available from the NCBI 
GEO archive GSE132448.
Bioinformatic analyses
Raw sequencing reads were trimmed and quality checked 
using Trimmomatic (0.36) [22] and FastQC (0.11.5) 
[23]. Trimmed reads were aligned to the human genome 
(GRCh 38.87) using Bowtie2 (2.3.2) [24] with additional 
parameters of ‘no mismatches’ and ‘–very-sensitive-local’. 
Duplicate reads were removed using Picard tools (2.10.4) 
[25]. Additional replicate quality control was performed 
using deepTools (2.5.3) [26] and in-house scripts: https ://
githu b.com/regan haywa rd/Manus cript s-code.
Peak calling of open chromatin regions was performed 
using MACS2 (2.1.1) [27] in paired-end mode, with addi-
tional parameters of ‘–no-model –broad –q 0.05′ and 
MACS2 predicted extension sizes. Care was taken to 
ensure parameters were best suited for FAIRE-seq data, 
particularly as peaks are generally broader than other 
methods as well as exhibiting a slightly higher back-
ground signal [28]. All replicates were called separately, 
with significant peaks determined against the software-
predicted background signal. Any peaks that fell within 
ENCODE blacklisted regions (regions exhibiting ultra-
high signal artefacts) [29], or were located on non-stand-
ard chromosomes such as (ChrMT and ChrUn) were 
removed. At this point, we chose a trade-off between 
sequencing depth and retaining a higher number of rep-
licates for each condition. This was due to a combination 
of stringent filtering steps and discarding any chlamydial 
mapped reads, resulting in medium to low coverage 
across the human genome. By not merging replicates, 
we acknowledge the loss of sequencing depth, but gain 
robust results through the creation of consensus peak 
sets which focused our analysis on reoccurring peaks/
regions.
Consensus peak sets were created by combining sig-
nificant peaks from the infected and mock-infected 
replicates for each time using Diffbind [30]. Peaks were 
removed if they appeared in less than two replicates. 
Reads were counted under each peak within each consen-
sus peak set; the resulting read depths were normalised 
to their relative library sizes. The resulting count matrices 
from each consensus peak set were subsequently used to 
examine differences in chromatin accessibility between 
infected and mock-infected replicates at each time using 
the built in DESeq2 method of Diffbind (FDR < 0.05). This 
created a list of differential chromatin-accessible regions 
with fold-changes relative to the mock-infected condi-
tions. While FAIRE enrichment is designed to recover 
open chromatin regions, our time-matched infected 
and mock-infected experimental design enables cor-
responding patterns of closed chromatin to be inferred 
by comparison between matched regions with negative 
fold-changes. Furthermore, we make the assumption that 
open and closed chromatin are directly associated with 
an increase or decrease in gene expression, respectively. 
As these data are a snapshot of infection events, this may 
not capture the dynamism of the infection response. For 
example, some regions of open chromatin may be in the 
process of being closed. Additionally, open chromatin 
regions may be facilitating the binding of transcriptional 
repressors, resulting in decreased expression.
Annotation of the set of differential chromatin-acces-
sible regions was performed with Homer (v4.9) [31] 
and separated into three main categories: Intragenic, 
Promoter and Intergenic. Intergenic: located > 1 kbp 
upstream of the transcriptional start site (TSS), or down-
stream from the transcription termination site (TTS); 
Promoter: located within 1kbp upstream or 100  bp 
downstream of the TSS (all promoter regions taken from 
RefSeq); and, intragenic: annotated to a 3′UTR, 5′UTR, 
intron, exon, TTS, miRNA, ncRNA or a pseudogene. 
When regions overlapped multiple features, the resulting 
annotation was ordered by promoter, intragenic feature, 
then intergenic regions. To identify enhancers, all inter-
genic regions were compared against enhancer regions 
from HeLa cells using Hacer [32], Enhancer-atlas [33] 
and dbSuper [34]. The use of Hacer allowed enhanc-
ers from ENCODE and FANTOM5 to also be used. All 
enhancer regions were converted from hg19 to hg38 
using the UCSC LiftOver tool [35].
Results within this manuscript show that 49% of the 
differently chromatin-accessible regions enriched in this 
chlamydial infection data are intergenic. Additional pre-
diction-based software analyses would likely reduce the 
number of intergenic regions by predicting additional 
features such as silencers, insulators and possibly more 
enhancers. Although extremely useful in the right setting, 
we chose not to run prediction-based tools as we wanted 
the results to be less speculative and only highlight sig-
nificant infection-relevant events.
Bimodality coefficients for the frequency distribution 
plots were calculated using the R-package Modes [36]. 
Long non-coding RNAs (lncRNA) were identified using 
data from HeLa cells [37], using a screen score > 2.
Motif analysis was performed with Homer [31]. Tar-
get sequences were regions with significant differential 
chromatin accessibility as identified by DESeq  2, while 
the number of background sequences were software-
determined, randomly selected regions throughout the 
human genome (excluding target regions and normal-
ised for GC content). Additional parameters included 
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using a hypergeometric distribution, searching for motifs 
between 8- and 16-bp long and allowing for four mis-
matches. To confirm motif significance within the 120 
conserved regions, the number of background sequences 
was varied, and only motifs that appeared across a con-
sensus of values were retained. Motif enrichment was 
also performed with Homer [31], followed by filtering 
and bioinformatic assessment of human tissue specific-
ity where possible. Time-specific TF filtering was applied 
by using parameters of p value < 0.001 and > 5% of tar-
get sequences. For the 120 conserved regions across all 
times, TFs were filtered based on a p value < 0.05. For 
significant de novo TFs, motif matrices were compared 
against the Jaspar [38] and TomTom [39] databases 
Enriched TF motifs were retained only if the Homer 
annotation matched top hits in Jaspar or TomTom, and 
were also human tissue specific. Furthermore, due to the 
strict filtering and application of thresholds to determine 
the final set of TF motifs, it is possible that TFs with weak 
binding sites that are infection relevant may be missed.
All identified TFs from the conserved and time-specific 
regions were compared to publicly available gene expres-
sion data to ensure that each TF could be expressed in 
HEp2 cells (unpublished data from dual RNA-Seq of 
C. trachomatis serovar E in HEp-2 cells over time). For 
infection relevance, TF expression was also examined 
across a range of different times (0.5, 1.5, 3, 6, 12, 24, 30 
and 48 h), cell lines (HEp2, HeLa and End1) and across 
different C. trachomatis-based infection models [40–42] 
and (unpublished data as described above).
When only small numbers of genes were recovered, 
enrichment was performed manually using publicly avail-
able databases, including NCBI [43], Uniprot [44], Wiki-
Genes [45] and GeneCards [46]. Gene Ontology [47] 
analysis was performed on the 48-h time-specific differ-
ential chromatin regions as the higher number of input 
genes enabled significance. In-house scripts and code 
used throughout this manuscript are available at https ://
githu b.com/regan haywa rd/Manus cript s-code.
Results and discussion
Chromatin accessibility landscapes of Chlamydia‑infected 
and mock‑infected cells
We applied FAIRE-Seq to C. trachomatis serovar 
E-infected and mock-infected human HEp-2 epithe-
lial cells in triplicate at 1, 12, 24, and 48 h post-infection 
(hpi). Following initial quality control measures, a single 
C. trachomatis-infected replicate was identified as an 
outlier and was removed from further analysis. Signifi-
cant peaks, representing regions of open chromatin in 
either the mock-infected or infected conditions, were 
identified from reads mapped to the human genome; 
with 52,584,839 mapped reads for mock-infected 
replicates and 98,802,927 mapped reads for Chlamydia-
infected replicates (151,387,766 in total) (Additional 
file 1). Each peak file was then examined in IGV to ensure 
peaks were dispersed genome-wide without discernible 
chromosomal biases (Additional file 2). The total number 
of significant peaks from each replicate varied across the 
examined times and conditions, ranging between 1759 
and 17,450 peaks (Fig. 1a).
Diffbind [30] was used to group and filter peaks at each 
time post-infection by removing regions with low cover-
age, or any regions not represented across a consensus of 
replicates (Fig.  1b). After normalisation for library size, 
principal component analysis (PCA) of the consensus 
peak sets led to the removal of one further outlier at 24 h 
(mock-infected). The remaining peak sets exhibit tight 
clustering between mock-infected and infected condi-
tions, respectively, at each time (Fig. 1c). Total consensus 
peak numbers increased across the chlamydial develop-
mental cycle, independent of the total mapped reads over 
time.
C. trachomatis infection is associated with temporal 
changes to chromatin accessibility in host cells
We identified genomic regions with significant differ-
ences in chromatin accessibility between infected and 
mock-infected conditions throughout the development 
cycle (FDR < 0.05). The resulting set of differential chro-
matin-accessible regions identifies both open and closed 
chromatin (relative to mock-infection). The total num-
ber of significant differentially accessible regions rose 
over the development cycle, with the number of regions 
increasing (3.6×) from 1 hpi (864) to 48 hpi (3128) 
(Fig.  2a). Open chromatin regions predominate over 
closed chromatin regions at each time (86–99%), sug-
gesting that host cell transcription and regulatory activ-
ity increases in response to infection. Closed chromatin 
regions also increase over time, but at a much lower fre-
quency. This may be an artefact of FAIRE enrichment, 
which is designed to specifically recover open chromatin.
At 12 h, the number of significant differentially acces-
sible regions was lower (8%), compared to the other times 
(64% at 1 hpi, 43% at 24 hpi and 72% at 48 hpi). The num-
ber of mapped reads was similar for all 12-h replicates 
across conditions, and similar to other times, suggest-
ing minimal bias from the variability of the underlying 
mapped reads (Additional file  1) and significant peaks 
(Fig. 1a). In addition, each replicate had consistent peak 
coverage across the human genome (Additional file  2). 
Furthermore, the 12-h peak annotation is similar to other 
times (Fig. 3b), and the distribution of peaks around the 
TSS (Fig.  3d) are within promoter regions, as also seen 
at 48 h (Fig.  3d). Thus, in the absence of any discern-
ible bias, the lower number of significant differentially 
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accessible regions at 12 h may reflect a lower efficiency of 
formaldehyde-crosslinking, or that this time in the course 
of chlamydial infection is relatively quiescent.
120 differentially accessible chromatin regions are 
common at all examined times (Fig.  2b), indicating a 
conserved response to chlamydial infection-associated 
events or general disruption of cellular homeostasis, irre-
spective of infection progression. In addition, unique sets 
of differentially accessible regions are found at each time 
post-infection, also highlighting the dynamism of the cel-
lular response to infection over time, particularly at 48 
hpi (Fig.  2b). Differential chromatin-accessible regions 
were annotated based on four categories (intragenic, 
enhancer, promoter and intergenic) as described in the 
Methods, and portrayed in Fig.  3a. It should be noted 
that although the enhancer region displayed in the figure 
is upstream of an associated promoter, they can appear 
anywhere throughout the genome. Enhancers often 
interact with genes through looping of DNA (Fig.  3a), 
but can also interact through tracking, linking and relo-
cation mechanisms [34]. Most infection-associated dif-
ferential chromatin-accessible regions were annotated 
to either intergenic or intragenic regions (Fig. 3b). Inter-
genic regions spanned considerable distances upstream 
and downstream from the closest gene (Fig.  3c), while 
enhancers that were identified from within these regions 
appear much closer to the TSS. Intragenic regions were 
predominantly (> 90%) annotated to intronic regions 
Fig. 1 Identifying significant peaks and creating consensus peaksets. a Significant peaks per replicate (p value < 0.05). b Consensus peaks were 
created for each time by combining significant peaks from Chlamydia-infected and mock-infected conditions, retaining peaks which appeared 
in > 2 replicates. c PCA plots demonstrating tight clustering within each consensus peak set grouping infected and mock-infected replicates
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(Additional file 3), consistent with other chromatin acces-
sibility studies [48, 49], and the overall distribution of 
protein-coding genes within the human genome [50]. The 
distribution of differential chromatin-accessible regions 
around TSSs (± 5  kb) at 12 and 48 hpi show that many 
regions are in close proximity to TSSs, with many regions 
directly upstream. Due to the strict classification of over-
lapping RefSeq–based promoters (− 1000 to 100 bp from 
TSS) employed here, we are confident these regions rep-
resent infection-relevant activity. At 24 hpi we also see 
a large number of regions directly upstream of the TSS, 
but also an increase of regions and variability further up 
and downstream. At 1 hpi, the regions exhibit a slight 
bi-modal distribution (bimodality coefficient 0.67), with 
fewer regions directly surrounding the TSS (Fig.  3d). 
The increased number of regions not immediately sur-
rounding TSSs at 1 and 24 hpi may suggest additional 
regulatory mechanisms such as different transcription 
initiation sites, or that differential intron/exon usage may 
be contributing to, or otherwise influencing chromatin 
accessibility upon chlamydial infection.
Differential chromatin accessibility at promoter regions
The proportion of all differentially accessible regions 
mapping to promoter regions is 4 (0.5%) at 1 hpi, 14 
(4.8%) at 12 hpi, 21 (1.5%) at 24 hpi and 265 (8.5%) at 48 
hpi (Fig. 4a). Notably, 48 hpi exhibits a > tenfold increase 
in the number of significant regions compared to 24 hpi, 
with the majority of regions showing a reduction in chro-
matin accessibility, likely representing downregulation of 
the associated genes (Fig.  4a). The large number of dif-
ferentially accessible chromatin regions within promot-
ers at 48 h is a likely reflection of the diversity of events 
occurring at this late stage of the developmental cycle, 
including apoptosis, necrosis, lysis and cellular stress. 
Associated 48 hpi genes are linked with heat-shock stress 
(DNAJB1, DNAJB5, DNAJC21 and HSPA1B), cell defence 
(ILF2, MAP2K3 and STAT2), and cell stress/apoptosis 
Fig. 2 Changes in chromatin accessibility over the chlamydial developmental cycle. a Volcano plots highlighting changes in chromatin accessibility 
between infected and mock-infected conditions. Regions of closed chromatin are represented as blue dots, while open chromatin regions are red 
dots. Peaks unique to a specific time have darker shading. Percentages above the plots show the proportion of consensus peaks with significant 
changes of chromatin accessibility between conditions (FDR < 0.05). b Unique and conserved regions of differential chromatin accessibility across 
the developmental cycle
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(ATF3, PPM1B, GAS5, BAG1 and TMBIM6). ATP7A, 
which has a promoter exhibiting an increase in chroma-
tin accessibility, is a key regulator of copper transport 
into phagosomes as part of a host cell response to intra-
cellular infection [51, 52].
Fifteen promoter-specific differentially accessible 
regions are found at two or more times. Two promoter 
regions are associated with genes encoding sorting nexin 
16 (SNX16) and oligosaccharyltransferase complex subu-
nit (OSTC), respectively (Fig.  4b). The promoter region 
of OSTC exhibits increased chromatin accessibility at 
24 and 48 h; OSTC is linked to cellular stress responses 
[53]. Conversely, SNX16 shows a reduction in chroma-
tin accessibility at both 1 and 48 hpi. Sorting nexins are 
a family of phosphatidylinositol-binding proteins shar-
ing a common PX domain that are involved in intracel-
lular trafficking. Sorting nexins are a key component of 
retromer, a highly conserved protein complex that recy-
cles host protein cargo from endosomes to plasma mem-
branes or the Golgi [54]. Retromer is targeted by several 
intracellular pathogens, including Chlamydia, as a key 
strategy for intracellular survival [55]. The C. trachoma-
tis effector protein, IncE, binds to sorting nexins 5 and 
6, disrupting retromer-mediated host trafficking path-
ways [55] and potentially perturbing the endolysomal-
mediated bacterial destruction capacity of the host cell 
[56]. However, SNX16 is a unique member of this fam-
ily, containing a coiled-coil domain in addition to a PX 
domain, and is not associated with retromer [57]. SNX16 
is instead associated with the recycling and trafficking 
of E-cadherin [57], which mediates cell–cell adhesion 
in epithelial cells, and is associated with a diversity of 
tissue-specific processes, including fibrosis and epithe-
lial–mesenchymal transition (EMT) [58]. Separately, C. 
trachomatis infection has been shown to downregulate 
E-cadherin expression via increased promotor meth-
ylation, potentially contributing to EMT-like changes 
[59]. Thus, downregulation of SNX16, as inferred by the 
observed reduction in promotor-associated chromatin 
accessibility may contribute to chlamydial fibrotic scar-
ring outcomes. In other bacterial pathogens, modulation 
of E-cadherin is a known virulence mechanism where it 
Fig. 3 Annotation of significant peaks. a Example illustration of annotating significant differential peaks to enhancer, promoter, intragenic or 
intergenic regions. b Number of peaks per annotated category, separated by time. c All intergenic peaks plotted based on their proximity to the TSS 
of the closest gene. All enhancers were identified from within these regions and are coloured green. d Frequency distribution of significant peaks 
and proximity to the TSS of their associated genes (± 5 KB)
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is degraded by proteases, such as HtrA, disrupting tight 
and adherens junctions to facilitate invasion through 
the epithelial barrier [60, 61]. Although chlamydial HtrA 
has been detected outside the inclusion and in exported 
blebs [62], E-cadherin has not yet been identified as a 
chlamydial HtrA target. Nevertheless, HtrA has been 
shown to be critical for in  vivo chlamydial infections, 
indicating that this functionality may be revealed in the 
future [63].
Genes in immediate proximity to the promoter-spe-
cific differentially accessible chromatin regions were 
compared to genes containing differentially accessible 
intragenic peaks (Fig.  4c). Of the 12 genes identified, 
only one (CSMD3) appeared at more than one time point 
post-infection. All genes exhibited changes in chromatin 
accessibility at intronic regions, except DNAJB5, which 
exhibited an increase in chromatin accessibility at its 
promoter and TTS. DGKB was the only gene to exhibit 
changes in chromatin accessibility at its promoter and 
at more than one intronic region, each with decreased 
accessibility. DGKB is a diacylglycerol kinase that metab-
olises 1,2-diacylglycerol (DAG) to produce phosphatidic 
Fig. 4 Differential chromatin accessibility within promoter regions. Heatmaps of significant differential peaks that were annotated to a promoter 
region. A All promoter regions from each time post-infection. B Promoters overlapping two or more different time points post-infection. Red and 
blue shading indicates fold-changes, while grey indicates no significant peaks. C Genes which contained significant differential peaks within a 
promoter region and also within one or more intragenic regions
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acid (PA), a key precursor in the biosynthesis of triacyl-
glycerols and phospholipids, and a major signalling mol-
ecule [64]. Chlamydia obtains and redirects host-derived 
lipids through multiple pathways [65].
Differential chromatin accessibility 
from enhancer‑regulated genes
Changes in chromatin accessibility of regions overlap-
ping tissue-specific transcriptional enhancers from a 
range of online databases were examined, identifying 
316 enhancer and 13 “super-enhancer” regulated genes 
(Fig.  5a, b). The super-enhancers used are defined as 
clusters of transcriptional enhancers that drive cell-
type-specific gene expression, are crucial to cell iden-
tity, and can contain disease-associated sequence 
variations [66]. Each enhancer can regulate more 
than one gene, explaining the substantial increase in 
enhancers (Fig.  3b). The majority of super-enhancers 
exhibited an decrease in chromatin accessibility, and 
were associated with genes mediating energy produc-
tion (SDHB and CDHC), cell protection (IER3) and the 
stress-regulated polyubiquitin gene UBC (ubiquitin 
C) [67] that is directly associated with ubiquitination, 
which is discussed in further detail below. Only one 
super-enhancer regulated gene appeared across three 
times post-infection (SGK1 at 1, 12 and 48 h), with an 
increase in chromatin accessibility. SGK1 (serum/glu-
cocorticoid regulated kinase) is associated with a range 
of different cellular processes that are crucial to repro-
ductive activities, with deregulation resulting in repro-
ductive disorders such as pregnancy loss, infertility and 
endometriosis [68].
The majority (78%) of enhancer regions were found 
at 48  h post-infection, and predominantly exhibited 
decreased chromatin accessibility (Fig.  5c). GO analy-
sis of closed chromatin regions identified the biologi-
cal process “long-chain fatty acid biosynthetic process 
(GO:0042759)” with the greatest significance (−log10 
p value 3.7). Decreased availability of long-chain fatty 
acids such as lauric acid and capric acid can inactivate 
C. trachomatis [69]. Reduced expression of other long-
chain fatty acids such as oleic acid also negatively impacts 
Fig. 5 Differential chromatin accessibility within enhancer regions. Significant differential peaks annotated as intergenic were compared against 
tissue-specific enhancers. a All enhancer regions across each of the four times. b Super-enhancer regulated genes. Red and blue shading indicate 
fold-changes, while grey indicates that no significant peaks were associated with that enhancer at that time. Some enhancer regions contain 
more than one peak, explaining why there are multiple fold-changes at some times. c Gene Ontology enrichment from the large number of 
enhancer-associated genes at 48 h. BP and MF correspond to biological process and molecular function
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growth and maintenance of the chlamydial inclusion 
membrane [70].
Four putative enhancer-regulated genes were further 
identified (CROCCP2, LA16c-321D4.2, LINC00514 and 
RP5-1173A5.1) by comparing chromatin accessibility 
changes that mapped to lncRNAs affecting cell growth 
and proliferation in HeLa cells [37]. Each region exhib-
ited decreased chromatin accessibility  (Log2FC rang-
ing between − 3.3 and − 4.6). Due to the relative lack of 
annotation of many lncRNAs, assigning function bioin-
formatically is challenging. However, these lncRNAs have 
been found to directly impact the survival of HeLa cells 
[71, 72].
Conserved host responses to infection over the chlamydial 
developmental cycle
The differential chromatin-accessible regions that are 
present at all four times during infection demonstrate 
a conserved host cell response to chlamydial infection 
(Fig.  2b). Time-specific differential chromatin acces-
sibility is also evident over the chlamydial developmen-
tal cycle (Fig. 2b). To investigate the conserved host cell 
response, we focused upon 58 of the 120 differential 
chromatin-accessible regions (intragenic, promoter or 
enhancer regions) identified above, excluding the likely 
ambiguous intergenic regions that arise due to the ambi-
guity of annotating to the closest feature (Fig.  6a). 56 
were within intronic regions, one within a 3′UTR (FECH) 
and one within a promoter region (RPL27A). Only 5 of 
these 58 significant differentially accessible regions show 
a decrease in overall chromatin accessibility. However, 
these same regions also exhibit increased chromatin 
accessibility at different intragenic locations at 48 hpi, 
further highlighting the potential for infection-related 
alternative splicing mechanisms (Fig. 6a). The remaining 
conserved differentially accessible regions were associ-
ated with genes involved in infection-relevant cellular 
processes, including C8A as part of the complement cas-
cade, and lipase activity from LIPI that is essential for 
chlamydial replication [73]; moreover, multiple genes 
(HDAC2, HNRNPUL1, NCOA7 and YAP1) are known 
transcriptional regulators [74–77]. We also examined any 
differential chromatin-accessible regions that appeared 
across three times, which identified further putative 
effects of chlamydial infection on the complement cas-
cade. Key components of the membrane attack complex 
(MAC) and complement activation pathways exhibit 
increased differential chromatin accessibility (C8B at 1, 
12 and 24 h and CFHR5 at 24 and 48 h). Conversely, C6 
exhibits decreased chromatin accessibility at 48 h.
All conserved differentially accessible regions were also 
examined for known transcription factors (TF) motifs in 
order to identify any potential master regulators of infec-
tion responses (Fig. 6b). Four TFs were identified (ETS1, 
POU3F2, TFAP4 and PKNOX1), represented by puta-
tive motifs within 49 different intergenic and intragenic 
regions. An increase in chromatin accessibility was seen 
at all binding sites and across all time points. TFAP4 
(Transcription Factor AP-4) functions as an activator of 
gene-expression of both cellular and viral genes during 
cellular differentiation [78]. ETS1 (ETS Proto-Oncogene 
1, Transcription Factor) also functions as an activator and 
is able to directly control expression levels of cytokine 
and chemokine genes [79, 80]. Each of these TFs have 
binding sites that fall within un-annotated intergenic 
regions. For each of the four TFs above, we further exam-
ined all significant differentially accessible chromatin 
regions that contained the associated motif. Regions that 
mapped to intergenic features were then compared to 
publicly available gene expression data from different C. 
trachomatis-based infection settings, as described in the 
methods (Additional file 4). ETS1, TFAP4 and PKNOX1 
demonstrate decreases in expression across nine dis-
tinct datasets, with the greatest changes occurring at 3 h 
post-infection.
Time‑specific host responses to infection 
over the chlamydial developmental cycle
We identified unique differentially accessible chroma-
tin regions across the chlamydial developmental cycle 
(Fig. 7a). At 1, 12 and 24 hpi, there are a relatively small 
number of significant differential chromatin-accessible 
regions. In contrast, 48 hpi exhibits over 1400 regions, 
likely reflecting the diverse processes associated with 
the end of the in  vitro developmental cycle. As above, 
we focused on differential chromatin accessibility within 
promoters, enhancers and intragenic regions at each 
time: 50 at 1 hpi, 17 at 12 hpi, 27 at 24 hpi and 866 at 48 
hpi (Fig. 7b, Additional file 5). We illustrate the in vitro 
C. trachomatis developmental cycle over three stages 
(early, mid and late), giving a broad visual representation 
of known biological events (Fig.  7c). Due to the limited 
Fig. 6 Conserved host cell response to infection. a 120 differentially accessible regions found in all four times were extracted, representing a 
conserved host cell response to infection. Intergenic regions were removed due to the ambiguity of annotating to the closest feature. If a gene 
contained more than one peak within a specific time, the different fold changes are split out evenly within the column at that time. b Significant 
motifs, enriched transcription factors (TFs) and associated information based on the associated chromatin accessibility within these conserved 
regions
(See figure on next page.)
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Fig. 7 Enrichment of time-specific differential chromatin regions. a The numbers of significant differential chromatin-accessible regions at each 
time. b The annotation of each of these regions. c The in vitro C. trachomatis developmental cycle separated into three stages, representing known 
biological events from the times that were examined. d Annotated time-specific differential chromatin regions associated with 1 h (d), 12 h (e) and 
24 h (f). Where genes have been grouped into annotated categories, multiple underlying sources were used for verification. g At 48 h, a substancial 
increase in genes allowed Gene Ontology (GO) enrichment. All three GO categories were enriched, with the top ten p values across the categories 
displayed
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number of differentially accessible chromatin regions at 
the first three times, all associated genes at those times 
were manually annotated, as described earlier.
At 1 hpi, increased chromatin accessibility was asso-
ciated with a variety of genes involved in the regula-
tion of host cell defences (CD44, IFNAR1, LGALS8, 
STAT1, SLA2 and DDAH1), transcription and transla-
tion (ZNF461, ZNF800, PHF2, RPS13 and SIN3A), the 
cell cycle (NIPBL, CEP57L1 and CMTM4) and BCL2L14 
(apoptosis facilitator Bcl-2-like protein 14) a member of 
the Bcl-2 Family of proteins that are linked to apopto-
sis [81] (Fig.  7d). At 12  h, four ncRNAs were identified 
(RPPH1, RN7SK, RN7SL2 and RMRP) that are involved 
in RNA processing, signalling and transcriptional regu-
lation [82–85]. The remaining genes at 12  h exhibited 
decreased chromatin accessibility, encompassing the cell 
cycle and DNA replication (SDCCAG8 and ORC2), and 
ubiquitination (PJA2 and FBXO46) (Fig. 7e). At 24 h, all 
genes were associated with decreased chromatin acces-
sibility and were grouped into two sub-categories: cell 
cycle (WAPL, SMARCB1 and CDC20) and energy pro-
duction (HK1, ACO1 and SLC25A13) (Fig. 7f ).
Increased changes to differential chromatin accessibility 
at the end of the developmental cycle
The large number of genes associated with differential 
chromatin accessibility at 48  h permitted GO enrich-
ment analysis to be performed, with the underlying genes 
distinguished by increased chromatin and decreased 
chromatin accessibility (Fig.  7g). Significantly enriched 
ontologies associated with regions of increased chro-
matin accessibility include the ErbB signalling pathway 
(GO:1901184), which is linked to a wide range of cellular 
functions including growth, proliferation and apoptosis. 
ErbB transmembrane receptors are also often exploited 
by bacterial pathogens for host cell invasion [86]. Nota-
bly, epidermal growth factor receptor (EGFR), a member 
of the ErbB family, is the target receptor for C. pneumo-
niae Pmp21 as an EGFR-dependent mechanism of host 
cell entry [87]. The C. trachomatis Pmp21 ortholog, 
PmpD, also has adhesin-like functions [88], however the 
host ligands are unknown. Nevertheless, EGFR inhibi-
tion results in small, immature C. trachomatis inclu-
sions, with calcium mobilisation and F-actin assembly 
disrupted [89], indicating the functional importance of 
EGFR and the ErbB signalling pathway for C. trachomatis 
attachment and development.
Three enriched biological processes share the term 
‘cell–cell adhesion via plasma membrane adhesion mol-
ecules’ (GO:0098742, GO:0016339 and GO:0007157). 
Several genes common to these categories with infec-
tion-responsive differential chromatin accessibility are 
associated with cadherins (CDH4, CDH12, CDH17, 
CDH20, FAT4 and PTPRD), which are calcium-depend-
ent transmembrane glycoproteins associated with the 
actin cytoskeleton and an essential structural compo-
nent to maintain cells bind together [90]. Disruption of 
cadherin function has been described in C. trachomatis 
infection, and is linked to the alteration of adherens junc-
tions and the induction of epithelial–mesenchymal tran-
sition (EMT) events that may underlie chlamydial fibrotic 
outcomes [59, 91]. Altered chromatin accessibility for a 
further cadherin-relevant locus was apparent in the pro-
moter region of SNX16 (see above), suggesting that alter-
ation or disruption of cadherin regulation is a key feature 
of chlamydial infection. The lipid-based ontology ‘Mem-
brane lipid biosynthetic process (GO: 0030148)’ was also 
associated with regions of open chromatin. Chlamydia 
scavenges a range of host cell-derived metabolites for 
intracellular growth and survival, particularly lipids [92, 
93].
Significantly enriched ontologies associated with 
regions of decreased chromatin accessibility include the 
‘I-Smad (inhibition of Smad) binding (GO:0070411)’. 
I-Smads (inhibitory-Smads) are one of three sub-types 
of Smads that inhibit intracellular signalling of TGF-β 
by various mechanisms including receptor-mediated 
inhibition [94]. This coincides with the appearance of 
‘Type 1 transforming growth factor beta receptor binding 
(GO: 0034713)’. In addition, four genes (SMAD2, DDX5, 
SMURF1 and SMAD6) are associated with closed chro-
matin and ‘R-Smad binding (GO: 0005814)’, which are 
part of the R-Smad sub-family that regulates TGF-β 
signalling directly [95, 96]. TGF-β induces I-Smad 
expression, and has been hypothesised to be a central 
component of dysregulated fibrotic processes in Chla-
mydia-infected cells, provoking runaway positive feed-
back loops that generate excessive ECM deposition and 
proteolysis, potentially leading to inflammation and scar-
ring [16].
We also identify 11 genes localised within the cel-
lular component ‘Microtubule organising centre (GO: 
0044450)’. Dynein-based motor proteins have been 
shown to move the chlamydial inclusion via the internal 
microtubule network to the MTOC (microtubule-organ-
ising centre); the close proximity to the MTOC is thought 
to facilitate the transfer of host vesicular cargo to the 
chlamydial inclusion [97].
Two similar ontologies ‘Ubiquitin-like protein ligase 
binding (GO: 0044389)’ and ‘Ubiquitin protein ligase 
binding (GO: 0031625)’ are involved in ubiquitination 
and protein quality control. The eukaryotic ubiquitina-
tion modification marks proteins for degradation and 
regulates cell signalling of a variety of cellular processes, 
including innate immunity and vesicle trafficking [98]. 
The deposition of ubiquitin onto intracellular pathogens 
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is a conserved mechanism found in a diverse range of 
hosts [99]. In Chlamydia, host cell ubiquitin systems 
can mark chlamydial inclusions for subsequent destruc-
tion [100] and there is emerging evidence that various 
Chlamydia species, using secreted effectors and other 
proteins, are able to subvert or avoid these host ubiqui-
tination marks for intracellular survival [100, 101]. Our 
observation of decreased chromatin accessibility of 
numerous ubiquitination genes, further highlighting the 
complex role of ubiquitination in chlamydial infection.
Identification of transcription factor motifs
Putative TFs were identified from enriched motifs within 
all significant differential chromatin-accessible regions 
at each time post-infection (Additional file 6). Eleven of 
the most significant TF motifs are shown in Table 1 and 
span the chlamydial developmental cycle. IRF3 (Inter-
feron Regulatory Factor) motifs are enriched at 1 hpi; 
IRF3 is a key transcriptional regulator of type I inter-
feron (IFN)-dependent innate immune responses and is 
induced by chlamydial infection. The type I IFN response 
to chlamydial infection can induce cell death or enhance 
the susceptibility of cells to pro-death stimuli [102], but 
may also be actively dampened by Chlamydia [103, 104]. 
Specificity Protein 1 (Sp1) is a zinc-finger TF that binds 
to a wide range of promoters with GC-rich motifs. Sp1 
may activate or repress transcription in a variety of cellu-
lar processes that include responses to physiological and 
pathological stimuli, cell differentiation, growth, apop-
tosis, immune responses, response to DNA damage and 
chromatin remodelling [105, 106].
The majority of TF motifs enriched at 48 h correspond 
to Krüppel-like-factors (KLFs). KLFs are zinc-finger TFs 
in the same family as Sp1, which is also enriched at 48 h. 
The members of this large family orchestrate a range of 
paracrine and autocrine regulatory circuits and are ubiq-
uitously expressed in reproductive tissues [107]. Dys-
regulation of KLFs and their dynamic transcriptional 
networks is associated with a variety of uterine patholo-
gies [107]. We find motif enrichment for five distinct 
KLFs (KLF3, KLF5, KLF6, KLF9 and KLF10) at 48  h, 
in addition to further KLFs at 12 (KLF3, KLF4, KLF6, 
KLF9), 24 h (KLF 10) and 48 h (KLF 4), when relaxing the 
initial filtering steps (Additional file  6). KLF5 is a tran-
scriptional activator found in various epithelial tissues 
and is linked to regulation of inflammatory signalling, 
cell proliferation, survival and differentiation [108]. KLF6 
is also a transcriptional activator ubiquitously expressed 
Table 1 Motifs and enriched transcription factors
Target sequences are significant differential peaks and background sequences are randomly selected throughout the genome to determine significance. A star (*) 
denotes a de novo motif where various sources were used to annotate the corresponding transcription factor





1 1e−13 10.53 3.84 IRF3*
24 1e−12 17.45 9.78 Homeobox*
48 1e−28 7.67 1.82 Sp1(Zf )
1e−22 6.30 1.58 KLF9(Zf )
1e−21 7.58 2.40 KLF3(Zf )
1e−15 32.58 23.46 MEF2C*
1e−13 9.81 4.90 KLF6(Zf )
1e−10 6.30 2.87 KLF10(Zf )
1e−7 11.06 7.18 KLF5(Zf )
1e−7 10.45 6.71 NFYB
1e−6 5.37 2.87 E2F3
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across a range of tissues and plays a crucial role in regu-
lating genes involved with tissue development, differen-
tiation, cell cycle control, and proliferation [109]. Target 
genes include collagen α1, keratin 4, TGFβ type I and II 
receptors, and others [110]. KLF3 is primarily associated 
as a strong transcriptional repressor associated with adi-
pogenesis and lipid metabolism [111], with expression 
rates varying across different tissues and cell types [109]. 
KLF9 and 10 also act as transcriptional repressors, but 
are ubiquitously expressed across a wider range of tissues 
[112]. KLF9 is a tumour suppressor [113] and regulates 
inflammation, while KLF10 has a major role in TGF-β-
linked inhibition of cell proliferation, inflammation and 
initiating apoptosis [114].
Histone deacetylases (HDACs) modify the core his-
tones of the nucleosome, providing an important func-
tion in transcriptional regulation [115], and many 
bacterial pathogens subvert HDACs to suppress host 
defences [15]. KLF9 and KLF10 share the co-factor 
Sin3A (SIN3 Transcription Regulator Family Member A) 
[112], which is also a core component of the chromatin-
modifying complex mediating transcriptional repres-
sion [116]. The Sin3a/HDAC complex is made up of two 
histone deacetylases HDAC1 and HDAC2. HDAC2 has 
increased chromatin accessibility at all four time points, 
and HDAC9 has increased chromatin accessibility at 1, 
24 and 48 h, further supporting the potential for histone 
modifications to be a component of the host cell response 
to chlamydial infection, or to be targets of chlamydial 
effectors [17].
All enriched TFs (Table 1) were compared against gene 
expression studies to ensure that each TF is expressed 
in HEp2 and HeLa cells from similar times (data not 
shown). To compare each TFs regulatory control on 
target genes, we examined the genes underlying sig-
nificant regions associated with each motif, comparing 
fold-change differences across different infection-based 
environments (Additional file 7). There is no consensus of 
gene expression associated with any of the enriched TFs. 
For example, previous studies have indicated that KLF3 is 
a strong transcriptional repressor; here, we see a range of 
fold-changes in the KLF3 regulated genes, with two of the 
three datasets examined showing only a slight decrease 
in mean expression (Additional file 7). We attribute these 
differences to the variability inherent to distinct infec-
tion models. Nevertheless, these results further highlight 
the diverse and complex mechanisms associated with the 
epithelial cell response to chlamydial infection.
Conclusions
We describe comprehensive changes to chromatin 
accessibility upon chlamydial infection in epithe-
lial cells in  vitro using FAIRE-Seq. We identify both 
conserved and time-specific infection-responsive 
changes to a variety of features and regulatory ele-
ments over the course of the chlamydial developmental 
cycle that may shape the host cell response to infection, 
including promotors, enhancers, and transcription fac-
tor motifs. Some of these changes are associated with 
genomic features and genes known to be relevant to 
chlamydial infection, including innate immunity and 
complement, acquisition of host cell lipids and nutri-
ents, intracellular signalling, cell–cell adhesion, metab-
olism and apoptosis.
Host cell chromatin accessibility changes are evident 
over the entire chlamydial developmental cycle, with a 
large proportion of all chromatin accessibility changes 
at 48  h post-infection. This likely reflects the conflu-
ence of late stages of developmental cycle events, how-
ever significant changes to chromatin accessibility are 
readily apparent as early as 1 h post-infection. We find 
altered chromatin accessibility in several gene regions, 
ontologies and TF motifs associated with ECM moie-
ties, particularly cadherins and their interconnected 
regulatory pathways, and Smad signalling. Disruption 
of the ECM is thought to be a central component of 
dysregulated fibrotic processes that may underpin the 
inflammatory scarring outcomes of chlamydial infec-
tion [16], and our data further highlights a central role 
of the ECM in epithelial cell responses to infection. 
We also identify factors that have not been previously 
described in the context of chlamydial infection, nota-
bly the enrichment of the KLF family of transcription 
factor motifs within differential chromatin-accessible 
regions in the latter stages of infection. Dysregulation 
of the biologically complex KLFs and their transcrip-
tional networks is linked to several reproductive tract 
pathologies in both men and women [107], thus our 
discovery of enriched KLF-binding motifs in response 
to chlamydial infection is compelling, given the scale 
and burden of chlamydial reproductive tract disease 
globally [3].
In summary, this is the first genome-scale analysis of 
the impact of chlamydial infection on the human epi-
thelial cell epigenome, encompassing the chlamydial 
developmental cycle at early, mid and late times. This 
has yielded a novel perspective of the complex host 
epithelial cell response to infection, and will inform 
further studies of transcriptional regulation and epi-
genomic regulatory elements in Chlamydia-infected 
human cells and tissues. Examination of the multifac-
eted human epigenome, and its potential subversion 
by Chlamydia, using in vivo mouse models of infection 
and ex vivo human reproductive tract tissues, will con-
tinue to shed light on how the host cell response con-
tributes to infection outcomes.
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Additional file 1. Summary of mapped reads by time and condition. 
Table summarising the number of mapped reads for each time and infec-
tion condition.
Additional file 2. Genome coverage plots. Significant peaks from each 
replicate as determined by MACS2. Screenshots are from IGV (Integrative 
Genomics Viewer) showing that all replicates contain significant peaks 
genome-wide (human genome) without any visual chromosomal bias.
Additional file 3. Annotation of all significant peaks. Annotation of all the 
significant peaks, with tabs separating genomic features and fold-change 
regulation.
Additional file 4. Conserved transcription factor expression. Motifs associ-
ated with each transcription factor (TF) as identified within the conserved 
regions. Genes associated with these regions were compared against 
relevant gene expression data to identify their level of regulation during 
infection. The TF POU3F2 was not able to be compared as the motif was 
only identified within intergenic regions that could not be overlapped. A) 
ETS1 TF. B) TFAP4 TF. C) PKNOX1 TF.
Additional file 5. Time specific regions. The list of time-specific differential 
chromatin-accessible regions. It should be noted that some genes in 
these lists are repeated at each time due to multiple peaks occurring at 
an annotated interval, that enhancers can affect more than one gene, and 
single genes can be affected by more than one enhancer.
Additional file 6. Complete list of motifs and transcription factors. The 
complete list of significant motifs and enriched transcription factors.
Additional file 7. Time-specific transcription factor expression. Motifs 
associated with each transcription factor (TF) (Table 1) were identified 
within significant differentially accessible regions. Genes associated with 
these regions were compared against relevant gene expression data to 
identify their level of regulation during infection. A) IRF3 TF from 1 h. B) 
Homeobox TF from 24 h. C‑K) Nine TFs identified at 48 h.
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